Expected Weight Loss: In the head-to-head SURMOUNT-5 trial published in The New England Journal of Medicine , tirzepatide was shown to be superior to semaglutide for reduction in body weight and waist circumference at 72 weeks among adults with obesity (without diabetes)
The following features would enhance the value of an obesity therapeutic, but would likely be assessed in follow-up trials or even post-approval: Additional efficacy in obesity-related co-morbidities
27 These data are compared with the quantitative detection of GLP1R by autoradiography, tested in those cases available with both formalin-fixed and fresh-frozen material
Characterizing diversity based on the chemical and nutritional composition of shiitake culinary-medicinal mushroom Lentinula edodes (Agaricomycetes) commonly cultivated in China
Aranaz P, Pea A, Vettorazzi A, Fabra MJ, Martnez-Abad A, Lpez-Rubio A, et al
It is new enough to represent the cutting edge of weight loss science, but it has been through enough clinical testing to have a well-defined safety and efficacy profile